Aytu Historical Cash Flow
| AYTU Stock | USD 1.62 0.02 1.25% |
Analysis of Aytu BioScience cash flow over time is an excellent tool to project Aytu BioScience future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 8.7 M or Other Non Cash Items of 4.6 M as it is a great indicator of Aytu BioScience ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Aytu BioScience latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Aytu BioScience is a good buy for the upcoming year.
Aytu |
About Aytu Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Aytu balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Aytu's non-liquid assets can be easily converted into cash.
Aytu BioScience Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Most accounts from Aytu BioScience's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Aytu BioScience current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aytu BioScience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.At this time, Aytu BioScience's Change To Operating Activities is comparatively stable compared to the past year.
Aytu BioScience cash flow statement Correlations
Click cells to compare fundamentals
Aytu BioScience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aytu BioScience cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 37.0M | 1.6M | (30.5M) | 3.6M | (3.0M) | (2.8M) | |
| Free Cash Flow | (28.4M) | (28.3M) | (28.8M) | (5.1M) | (1.4M) | (1.5M) | |
| Change In Working Capital | (12.6M) | 1.7M | (10.9M) | (5.8M) | (4.7M) | (4.4M) | |
| Begin Period Cash Flow | 11.3M | 48.3M | 49.9M | 19.4M | 23.0M | 24.1M | |
| Other Cashflows From Financing Activities | 90.5M | 31.3M | (4.9M) | (6.6M) | (2.8M) | (2.7M) | |
| Depreciation | 6.2M | 9.2M | 10.3M | 8.8M | 8.3M | 8.7M | |
| Other Non Cash Items | (10.0M) | (4.5M) | 76.7M | (404K) | 7.9M | 4.6M | |
| Total Cash From Operating Activities | (28.4M) | (26.0M) | (28.8M) | (5.1M) | (1.4M) | (1.5M) | |
| Net Income | (13.6M) | (58.3M) | (110.2M) | (17.1M) | (15.8M) | (16.6M) | |
| Total Cash From Financing Activities | 71.1M | 30.3M | 1.5M | 8.9M | (1.3M) | (1.2M) | |
| End Period Cash Flow | 48.3M | 49.9M | 19.4M | 23.0M | 20.0M | 12.1M | |
| Stock Based Compensation | 1.1M | 3.6M | 5.2M | 6.0M | 2.9M | 2.2M | |
| Net Borrowings | (16.2M) | (3.7M) | (5.2M) | (2.3M) | (2.1M) | (2.0M) | |
| Change To Netincome | 1.7M | 21.4M | 82.0M | 8.9M | 10.2M | 14.6M | |
| Change To Liabilities | 4.1M | (3.2M) | (7.7M) | 2.4M | 2.1M | 2.3M | |
| Change To Inventory | (7.0M) | 2.8M | 1.3M | (3.6M) | 2.3M | 2.4M | |
| Change To Account Receivables | (3.6M) | 1.5M | 6.5M | (7.2M) | 5.3M | 5.6M | |
| Investments | (5.7M) | (2.8M) | (3.2M) | (117K) | (329K) | (345.5K) | |
| Total Cashflows From Investing Activities | (5.7M) | (2.8M) | (3.2M) | (117K) | (134.6K) | (141.3K) | |
| Change To Operating Activities | (610.2K) | 596K | (11.0M) | 2.6M | 2.3M | 2.4M | |
| Other Cashflows From Investing Activities | (5.7M) | 40K | (70K) | (112K) | (100.8K) | (105.8K) | |
| Issuance Of Capital Stock | 65.7M | 45.1M | 11.7M | 15.6M | 3.5M | 3.3M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aytu Stock Analysis
When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.